- Home
- ACHR vs LNTH Comparison
ACHR vs LNTH Comparison
Compare ACHR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHR
- LNTH
- Stock Information
- Founded
- ACHR 2018
- LNTH 1956
- Country
- ACHR United States
- LNTH United States
- Employees
- ACHR N/A
- LNTH N/A
- Industry
- ACHR Aerospace
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ACHR Industrials
- LNTH Health Care
- Exchange
- ACHR Nasdaq
- LNTH Nasdaq
- Market Cap
- ACHR 6.4B
- LNTH 5.7B
- IPO Year
- ACHR N/A
- LNTH 2015
- Fundamental
- Price
- ACHR $10.61
- LNTH $81.47
- Analyst Decision
- ACHR Strong Buy
- LNTH Strong Buy
- Analyst Count
- ACHR 8
- LNTH 5
- Target Price
- ACHR $13.13
- LNTH $131.20
- AVG Volume (30 Days)
- ACHR 42.7M
- LNTH 952.8K
- Earning Date
- ACHR 08-07-2025
- LNTH 07-30-2025
- Dividend Yield
- ACHR N/A
- LNTH N/A
- EPS Growth
- ACHR N/A
- LNTH N/A
- EPS
- ACHR N/A
- LNTH 3.53
- Revenue
- ACHR N/A
- LNTH $1,536,699,000.00
- Revenue This Year
- ACHR N/A
- LNTH $4.63
- Revenue Next Year
- ACHR N/A
- LNTH $9.35
- P/E Ratio
- ACHR N/A
- LNTH $23.03
- Revenue Growth
- ACHR N/A
- LNTH 12.53
- 52 Week Low
- ACHR $2.82
- LNTH $73.11
- 52 Week High
- ACHR $13.92
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ACHR 53.08
- LNTH 50.75
- Support Level
- ACHR $9.76
- LNTH $78.74
- Resistance Level
- ACHR $11.06
- LNTH $85.31
- Average True Range (ATR)
- ACHR 0.58
- LNTH 2.28
- MACD
- ACHR 0.02
- LNTH 0.51
- Stochastic Oscillator
- ACHR 63.81
- LNTH 45.38
About ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.